dc.contributor.author | Neves, Fabio Fernandes | |
dc.contributor.author | Pott-Junior, Henrique | |
dc.contributor.author | Santos, Sigrid Sousa | |
dc.contributor.author | Cominetti, Marcia Regina | |
dc.contributor.author | Freire, Caio Cesar de Melo | |
dc.contributor.author | Cunha, Anderson Ferreira da | |
dc.contributor.author | Jordão Júnior, Alceu Afonso | |
dc.date.accessioned | 2023-08-18T14:02:43Z | |
dc.date.available | 2023-08-18T14:02:43Z | |
dc.date.issued | 2022-08-15 | |
dc.identifier | https://doi.org/10.1016/j.clnesp.2022.05.027 | por |
dc.identifier.citation | NEVES, Fabio Fernandes; POTT-JUNIOR, Henrique; SANTOS, Sigrid Sousa; COMINETTI, Marcia Regina; FREIRE, Caio Cesar de Melo; CUNHA, Anderson Ferreira da; JORDÃO JÚNIOR, Alceu Afonso. Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19. Clinical Nutrition ESPEN, v. 50, p. 322-325, 2022. Disponível em: https://repositorio.ufscar.br/handle/ufscar/18414. | * |
dc.identifier.issn | 2405-4577 | por |
dc.identifier.uri | https://repositorio.ufscar.br/handle/ufscar/18414 | |
dc.description.abstract | Several studies have shown conflicting results for the relationship between vitamin
D deficiency and COVID-19 outcomes. Here, we aimed to evaluate whether plasma 25(OH)D levels
predict mortality in adults admitted with COVID-19, considering potential confounders.
Methods: We conducted a retrospective cohort study that included 115 adults (age 62.1 ± 17.6 years, 65
males) admitted to a Brazilian public hospital for severely symptomatic COVID-19. Subjects were classified into two groups according to their plasma levels of 25(OH)D: sufficiency ( 50 nmol/L) and the
deficiency (<50 nmol/L). The diagnosis of COVID-19 was performed using real-time polymerase chain
reaction (qPCR). In addition, direct competitive chemiluminescence immunoassay assessed serum
25(OH)D levels.
Results: The all-cause 30-day mortality was 13.8% (95% CI: 6.5%e21%) in the group of patients with
sufficient plasma 25(OH)D levels and 32.1% (95% CI: 14.8%e49.4%) among those with deficient plasma
25(OH)D levels. Cox regression showed that plasma 25(OH)D levels remained a significant predictor of
mortality even after adjusting for the covariates sex, age, length of the delay between symptom onset
and hospitalization, and disease severity (HR ¼ 0.98, 95% CI: 0.96e1.00; p ¼ 0.02).
Conclusion: Vitamin D deficiency predicts higher mortality risk in adults with COVID-19. | eng |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | por |
dc.format.extent | 322-325 | por |
dc.language.iso | por | por |
dc.publisher | Universidade Federal de São Carlos | por |
dc.relation.ispartof | Clinical Nutrition ESPEN | por |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Brazil | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/br/ | * |
dc.subject | COVID-19 | por |
dc.subject | SARS-Cov-2 | por |
dc.subject | vitamina d | por |
dc.title | Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19 | eng |
dc.title.alternative | Deficiência de vitamina D prevê mortalidade hospitalar em 30 dias de adultos com COVID-19 | por |
dc.type | Artigo | por |
dc.publisher.initials | UFSCar | por |
dc.subject.cnpq | CIENCIAS DA SAUDE::MEDICINA::CLINICA MEDICA | por |
dc.description.sponsorshipId | 2020/06725-0 | por |
dc.publisher.address | Câmpus São Carlos | por |
dc.contributor.authorlattes | http://lattes.cnpq.br/2652568399519714 | por |
dc.identifier.url | https://clinicalnutritionespen.com/article/S2405-4577(22)00293-5/fulltext | por |
dc.publisher.department | Departamento de Medicina - DMed | por |
dc.citation.volume | 50 | por |
dc.contributor.authororcid | https://orcid.org/0000-0001-6536-3249 | por |